Prognosis and epidemiology of amyotrophic lateral sclerosis Analysis of a clinic population, 1997-2011

Neurology: Clinical Practice

Volumn 3, Issue 4, 2013, Pages 313-320

  Traxinger, Kim ^a   Kelly, Crystal ^a   Johnson, Brent A ^b   Lyles, Robert H ^b   Glass, Jonathan D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASE;

ADULT; AGE DISTRIBUTION; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY FUNCTION; SEX RATIO; SURVIVAL; SURVIVAL TIME; SYMPTOM; WEIGHT REDUCTION;

EID: 84887863595     PISSN: 21630402     EISSN: 21630933     Source Type: Journal    
DOI: 10.1212/CPJ.0b013e3182a1b8ab     Document Type: Article

References (19)

1. Chancellor AM, Slattery JM, Fraser H, Swingler R.J., Holloway SM, Warlow CP The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register. J Neurol 1993; 240:339-346.
2. Chio A, Calvo A, Moglia C., Mazzini L, Mora G. Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study. J Neurol Neurosurg Psychiatry 2011; 82:740-746.
3. Chio A, Logroscino G, Hardiman O., et al Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler 2009; 10:310-323.
4. Chio A, Mutani R, Mora G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 2003; 61:1826-1827; author reply 1827.
5. Czaplinski A, Yen AA, Appel SH Amyotrophic lateral sclerosis: early predictors of prolonged survival. J Neurol 2006; 253:1428-1436.
6. Czaplinski A, Yen AA, Simpson E.P., Appel SH Predictability of disease progression in amyotrophic lateral sclerosis. Muscle Nerve 2006; 34:702-708.
7. del Aguila M.A., Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 2003; 60:813-819.
8. Jablecki CK, Berry C, Leach J. Survival prediction in amyotrophic lateral sclerosis. Muscle Nerve 1989; 12:833-841.
9. Logroscino G, Traynor BJ, Hardiman O, et al Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry 2008; 79:6-11.
10. Okamoto K, Kobashi G, Washio M., et al Descriptive epidemiology of amyotrophic lateral sclerosis in Japan, 1995-2001. J Epidemiol 2005; 15:20-23.
11. Sabatelli M, Madia F, Conte A., et al Natural history of young-adult amyotrophic lateral sclerosis. Neurology 2008; 71:876-881.
12. Tysnes OB, Vollset SE, Larsen J.P., Aarli JA Prognostic factors and survival in amyotrophic lateral sclerosis. Neuroepidemiology 1994; 13:226-235.
13. Lee JR, Annegers JF, Appel SH Prognosis of amyotrophic lateral sclerosis and the effect of referral selection. J Neurol Sci 1995; 132:207-215.
14. Zoccolella S, Beghi E, Palagano G., et al Predictors of long survival in amyotrophic lateral sclerosis: a population-based study. J Neurol Sci 2008; 268:28-32.
15. Forsgren L, Almay BG, Holmgren G, Wall S. Epidemiology of motor neuron disease in northern Sweden. Acta Neurol Scand 1983; 68:20-29.
16. Murros K, Fogelholm R. Amyotrophic lateral sclerosis in Middle-Finland: an epidemiological study. Acta Neurol Scand 1983; 67:41-47.
17. Rudnicki SA. Estrogen replacement therapy in women with amyotrophic lateral sclerosis. J Neurol Sci 1999; 169:126-127.
18. Popat RA, Van Den Eeden SK, Tanner CM, et al. Effect of reproductive factors and postmenopausal hormone use on the risk of amyotrophic lateral sclerosis. Neuroepidemiology 2006; 27:117-121.
19. Norris FH, Denys EH, Sang K, Mukai E. The natural history of ALS in a specified population, with comments on risk factors, prognosis and symptomatic treatments. Rinsho Shinkeigaku 1989; 29:1485-1492.